Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0019 | 0.9 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |